CESPE Conference 2022 News Program

Manufacturing Innovations for a Sustainable (Bio)Pharmaceutical Industry

Conference opening, introductions and keynote

9h00: Registration

Welcome & conference opening
Rik Van de Walle, Rector UGent

Introduction to CESPE
Prof. Thomas De Beer, CESPE Director

Flanders R&D policies for better health and care – Towards Recovery Resilience
Kathleen D’Hondt, Policy Analyst, Department Economy, Science and Innovation – Flemish Government

Keynote ‘Healthcare Innovation: the crossroads of HealthTech and the (bio)pharmaceutical ecosystem’
Ann Van Gysel, CEO Medvia

Break (posters & exhibition booths)

Chemical drug substance manufacturing of the future

Drug Substance Manufacturing in 2030 – adaptive, connected & sustainable
Yves Vancleemput, Director Business Development, Janssen Pharmaceutica

The Future will flow, more and more in the pharmaceutical sector
Prof. Chris Stevens, UGent

Design of Sustainable Pharmaceutical Processes with Artifcial Intelligence
Maarten Dobbelaere, UGent

Biopharmaceuticals: a fast growing pipeline

Setting up a large scale clinical and commercial CAR-T manufacturing HUB in Ghent
Birk Vanderweeën, General Manager Europe, Legend Biotech

Networking lunch (posters & exhibition booths)

Continuous manufacturing of antibodies: the inevitable step towards sustainable drug manufacturing
Koen Dierckx, CEO SimAbs

Discovery and selection of therapeutic antibodies with drug-like properties
Prof. Hristo Svilenov, UGent

An academic’s journey to spin-out commercialization of a new manufacturing technology: continuous pharmaceutical lyophilization
Prof. Thomas De Beer, UGent & RheaVita

Towards efficient Drug Product Development & Controlled Manufacturing

Challenges and opportunities in drug product development
Fanny Stauffer, Drug Product Expert, UCB

Linking material proporties to their behavior during processing
Prof. Chris Vervaet, UGent

Process simulation & sustainable systems engineering as key element for future proof pharmaceutical manufacturing

Advanced process simulation for smart manufacturing process development, scale-up and operation
Wim Audenaert, CEO & Co-founder AM-Team

Sustainability Assessment in the pharmaceutical sector
dr. Lieselot Boone, UGent

Break (posters & exhibition booths)

(Bio)pharmaceutical manufacturing; staying ahead of what’s next

Panel discussion
Ann Van Gysel, CEO Medvia
Claire Skentelbery, Director General EuropaBio
Yves Vancleemput, Director Business Development, Janssen Pharmaceutica
Birk Vanderweeën, General Manager Europe, Legend Biotech
Prof. Thomas De Beer, CESPE Director
(moderation: Tineke Van hooland)

Pech Kucha presentations


Closing word
Sofie Bracke, Executive Councillor for Economy, Port and Sports, City of Ghent

Wouter De Soete, Manager CESPE
Christoph Portier, CESPE Operations Manager

Networking reception & Dinner

18h00 – 22h00
(posters & exhibition booths)

On this page you will find all the updates considering the program of our CESPE conference on Manufacturing Innovations for a Sustainable (Bio)Pharmaceutical Industry. At this event, there will be a mix of senior industry leaders, policy makers, academics and startups. There will be a variety of talks on chemical drug substance, drug product and biotech manufacturing, providing insights in both industrial and academic state-of-the-art. There will also be ample opportunities to network with all participants. 

What’s in it for you?
You will:

  • Have access to state-of-the-art science in the field of chemical drug substance, drug product and biotech manufacturing
  • Get to know groundbreaking and disruptive manufacturing technologies
  • Expand your professional network 
  • Learn more about our new facilities planned at Tech Lane Ghent Science Park, including cleanrooms to handle potent APIs 
  • Have the latest insights in the new Master in Pharmaceutical Engineering, unique in Flanders and launched in September ’22. 
  • Have discussion opportunities with talented PhD and postdoctoral researchers through interactive poster sessions
  • Learn about access to young talent through various master thesis opportunities

Other team members

Other research groups